Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹3,436.08 Cr
Market Cap
Total market value of companyP/E Ratio
174.16
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
4.95
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹7.48
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
0.73%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
8.82%
ROCE
Return on Capital Employed. >15% is goodNet Margin
2.41%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
1.43%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
20.49%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
3.77%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-10.60%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.76
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹299.22
Book Value
Net asset value per shareDividend Yield
0.15%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
51.20%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
4 points- •Neogen Chemicals maintains a strong promoter holding of 51.2%, signaling high confidence in its future and reducing external shareholding risks. This ownership level suggests a long-term commitment to the company's success.
- •The company exhibits a healthy operating profit margin (OPM) of 17.5%, indicating efficient cost management and strong pricing power in the specialty chemicals industry. This profitability is a key financial health indicator.
Weaknesses
6 points- •Neogen Chemicals has a high P/E ratio of 95.00, suggesting the stock may be overvalued relative to its earnings. Investors should carefully assess this valuation and the potential risks associated with such a high multiple.
- •The company's debt-to-equity ratio of 0.76 indicates a notable level of debt, which could elevate financial risk, particularly during economic downturns. This substantial debt requires close monitoring by investors.
Opportunities
3 points- •The specialty chemicals sector, where Neogen operates, is experiencing robust growth driven by increasing demand across various end-user industries. This trend presents significant expansion opportunities for the company.
- •Expanding global demand for specialized chemical solutions, particularly in emerging markets, offers Neogen Chemicals avenues for geographical expansion and increased sales volumes, leveraging its core expertise.
Threats
5 points- •Intense competition from larger, more established players in the specialty chemicals sector, some with superior financial metrics like higher ROCE, could pressure Neogen's market share and pricing power.
- •Volatility in raw material prices, a common challenge in the chemicals industry, could significantly impact Neogen's operating margins and profitability, especially given its current OPM of 17.50%.
Segment-wise Financial Analysis
Financial Results
Balance Sheet
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
No Balance Sheet Data Available
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
Recent Insider Transactions
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
HARIDAS THAKARSHI KANANI | 09 Apr 2025 | 10 Apr 2025 | 90.67 L | 13.38 L | - | SELL |
HARIN HARIDAS KANANI | 09 Apr 2025 | 10 Apr 2025 | 33.38 L | 13.38 L | - | BUY |
HARIDAS THAKARSHI KANANI | 11 Apr 2025 | 11 Apr 2025 | 61.54 L | 29.13 L | - | SELL |
BEENA HARIDAS KANANI | 11 Apr 2025 | 11 Apr 2025 | 30.13 L | 29.13 L | - | BUY |
HARIDAS THAKARSHI KANANI | 11 Apr 2025 | 15 Apr 2025 | - | 61.54 L | - | SELL |
HARIDAS THAKARSHI KANANI | 11 Apr 2025 | 15 Apr 2025 | 61.54 L | 61.54 L | - | BUY |
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1511.00 | +₹180.30 | +13.55% |
| R3 | ₹1442.20 | +₹111.50 | +8.38% |
| R2 | ₹1416.10 | +₹85.40 | +6.42% |
| R1 | ₹1373.40 | +₹42.70 | +3.21% |
| PIVOT | ₹1347.30 | 16.60 | 1.25% |
| CURRENT | ₹1330.70 | - | - |
| S1 | ₹1167.00 | -₹163.70 | -12.30% |
| S2 | ₹1235.80 | -₹94.90 | -7.13% |
| S3 | ₹1278.50 | -₹52.20 | -3.92% |
| S4 | ₹1304.60 | -₹26.10 | -1.96% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-56.6% vs avg
0.26L
(06 Mar 2026)Delivery %+13.7% vs avg
52.0%
(06 Mar 2026)Avg Volume (20D)20-day average
0.60L
(06 Feb - 06 Mar)Avg Delivery %Trend ↓
38.4%
(06 Feb - 06 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Asian Paints Ltd
2.34L ₹ Cr
Best Profit Growth
Camlin Fine Sciences Ltd
77.80 %
Highest Dividend Yield
Advanced Enzyme Technologies Ltd
1.75 %
Peer Comparison
| Company Name |
|---|
 Advanced Enzyme Technologies Ltd |
 Asian Paints Ltd |
 Balaji Amines Ltd |
 Camlin Fine Sciences Ltd |
 Chemplast Sanmar Ltd |
 Fineotex Chemical Ltd |
 Foseco India Ltd |
 Galaxy Surfactants Ltd |
 Indigo Paints Ltd |
 Jubilant Agri & Consumer Products Ltd |
 Kiri Industries Ltd |
 Laxmi Organic Industries Ltd |
 Rossari Biotech Ltd |
 Raghav Productivity Enhancers Ltd |
 Tatva Chintan Pharma Chem Ltd |
About
Neogen Chemicals Ltd
Neogen Chemicals Limited is an Indian specialty chemical manufacturer and supplier, established in 1989 and headquartered in Thane. Their primary business revolves around the production and sale of a diverse range of chemical compounds, catering to a broad spectrum of industrial sectors.
A significant portion of Neogen's product portfolio centers on organobromine compounds. This encompasses a wide variety of alkyl bromides, dibromoalkanes, and other bromine-based derivatives. They also offer specialty chloro compounds, organolithium compounds, and inorganic chemicals such as bromine compounds and lithium salts. The company's expertise extends to Grignard reagents and advanced intermediates, highlighting their proficiency in complex chemical synthesis.
Beyond the specific chemical compounds, Neogen provides a comprehensive suite of chemical services. This includes custom synthesis tailored to client-specific needs, along with contract manufacturing services for larger-scale production requirements. Their expertise covers various chemical reactions such as alkylation, acylation, and halogenation, showcasing their versatile capabilities in chemical transformation.
The company's diverse clientele spans a wide array of industries. Key sectors served include pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, and specialty polymers. Their global reach is demonstrated by exports to 31 countries, solidifying their position as a significant player in the international specialty chemicals market.
COMPANY FACTS - NEOGEN
Registered Address
1002, Dev Corpora, Cadbury Junction, Eastern Express Highway
Thane
MAHARASHTRA
IN
Tel: 912225497300
Website:https://neogenchem.com/
Investor Relations:http://neogenchem.com/investor-relations
Company Details
Group: Materials
Sector: Materials
Industry: Chemicals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 588
IPO Date: 08/05/2019
MANAGEMENT - NEOGEN
Mr. Haridas Kanani
Chairman Emeritus
Mr. Anurag Surana
Non-Executive Chairman of the Board
Mr. Gopikrishnan Sarathy
Chief Financial Officer
Ms. Unnati Kanani
Compliance Officer, Company Secretary
Dr. Harin Kanani
Managing Director, Executive Director
Mr. Triplicane Saikrishnan
Executive Director
Mr. Shyamsunder Upadhyay
Whole Time Director
Prof. Ranjan Malik
Non-Executive Independent Director
Mr. Manoj Pati
Non-Executive Independent Director
Mrs. Avi Sabavala
Non-Executive Independent Woman Director
Mr. Rajeshkumar Shah
Non-Executive Independent Director
Investor Questions Answered
Neogen Chemicals Ltd (NEOGEN) Stock FAQs
Get answers to the most common questions about Neogen Chemicals Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Neogen Chemicals Ltd (NEOGEN) is ₹1,330.7. Today, the stock has declined by ₹60.00 (4.31%), trading in a range of ₹1,321.2 to ₹1,390. The stock opened at ₹1,381.4 with a trading volume of 26,098 shares.
Neogen Chemicals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,436.08 crores, P/E ratio of 174.16, ROE of 0.73%, and ROCE of 8.82%. The dividend yield stands at 0.15%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Neogen Chemicals Ltd (NEOGEN) is ₹1,926, while the 52-week low is ₹966.7. Currently trading at ₹1,330.7, the stock is 37.9% away from its 52-week low and 30.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Neogen Chemicals Ltd stock at ₹1,330.7 depends on multiple factors. The stock is currently trading with a P/E ratio of 174.16 and P/B ratio of N/A. Today's performance shows a loss of 4.31%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Neogen Chemicals Ltd offers a dividend yield of 0.15%, which means for every ₹100 invested at the current price of ₹1,330.7, you can expect to receive approximately ₹0.15 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Neogen Chemicals Ltd's key financial metrics include: P/E Ratio: 174.16, P/B Ratio: N/A, ROE: 0.73%, ROCE: 8.82%, Dividend Yield: 0.15%, EPS: ₹7.48, Book Value: ₹299.22, Debt-to-Equity: 0.76, and Current Ratio: N/A. The company's market cap stands at ₹3,436.08 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Neogen Chemicals Ltd stock opened at ₹1,381.4 and is currently trading at ₹1,330.7, showing a decline of ₹60.00 (4.31%). The intraday high is ₹1,390 and low is ₹1,321.2. The trading volume stands at 26,098 shares, indicating moderate market participation today.
Neogen Chemicals Ltd has a Price-to-Earnings (P/E) ratio of 174.16, which means investors are willing to pay ₹174.16 for every ₹1 of earnings. With an EPS of ₹7.48, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Neogen Chemicals Ltd has a market capitalization of ₹3,436.08 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,330.7) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Neogen Chemicals Ltd has a book value of ₹299.22 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹1,330.7, which is 344.7% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Neogen Chemicals Ltd has a Return on Equity (ROE) of 0.73% and Return on Capital Employed (ROCE) of 8.82%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Neogen Chemicals Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Neogen Chemicals Ltd has a debt-to-equity ratio of 0.76, which measures the company's financial leverage by comparing total debt to shareholders' equity. This moderate ratio indicates balanced use of debt and equity. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Neogen Chemicals Ltd has an Earnings Per Share (EPS) of ₹7.48, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹1,330.7 and P/E ratio of 174.16, investors are paying 174.16 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Neogen Chemicals Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Neogen Chemicals Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Neogen Chemicals Ltd stock, consider: 1) Fundamental Analysis - Review P/E (174.16), ROE (0.73%), debt-to-equity (0.76), and growth rates. 2) Technical Analysis - Check 52-week range (₹966.70 - ₹1926.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹1330.70) with book value (₹299.22) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Neogen Chemicals Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹1,330.7 is 13207x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Neogen Chemicals Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹966.70 - ₹1926.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.76 indicates leverage. 4) Liquidity Risk - Based on trading volume of 26,098 shares. 5) Valuation Risk - P/E of 174.16 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Neogen Chemicals Ltd operates in the industry with key metrics: P/E ratio of 174.16, ROE of 0.73%, market cap of ₹3,436.08 crores, and dividend yield of 0.15%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.76), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Neogen Chemicals Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹1,330.7, with a 52-week range of ₹966.70 to ₹1926.00. Based on fundamentals like P/E (174.16), ROE (0.73%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Neogen Chemicals Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹1330.70. 2) Fundamental Deterioration - Declining ROE (currently 0.73%), increasing debt (D/E: 0.76), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Neogen Chemicals Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.15%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu